SSIINasdaq

SS Innovations International Inc.

Healthcare·Oncology·Commercial·Gurugram, India
OncologyNeurologyCardiovascular

SS Innovations International Inc. (SSII): 1 pipeline candidate · ~48 mo cash runway · 1 clinical trial. Updated within the last hour.

8.3/10

BioSniper Score

5-factor signal · derived from public data

Cash Runway10.0

47.6 months

Financial Health8.7

D/E 0.66 · 3% dilution

Pipeline Maturity10.0

Lead: Approved

Pipeline Breadth3.3

1 candidate

Catalyst MomentumN/A

N/A

Insider Signal9.5

3 buys · 0 sells (180d)

A transparent, data-derived signal for SS Innovations International Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.

Key Financials

Market Cap

$694.5M

Cash

$24.0M

Quarterly Burn

$2.3M

Runway

47.6 mo

Revenue

$11.1M

Cash Runway vs Catalysts

Tracked catalysts land within the current projected cash runway.

Cash ends ~Jun 2030
Today~52 mo out
Catalyst within runway

Pipeline (1 candidate)

Institutional Holdings

Source: SEC Form 13F · as of Mar 2026

Institutional holders

16

Total value held

$650K

HolderSharesValue
geode capital management, llc36,276$181K
alti global, inc.20,555$103K
ifc & insurance marketing, inc.16,730$84K
state street corp15,586$78K
pnc financial services group, inc.13,627$68K
goldman sachs group inc10,601$53K
millennium management llc10,226$51K
morgan stanley3,000$15K
nfsg corp1,316$7K
steward partners investment advisory, llc1,100$6K

Showing top 10 of 16 institutional holders of SS Innovations International Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.

1 clinical trial·CEO: Dr. Sudhir Prem Srivastava M.D.

Frequently asked questions

How many drug candidates are in SS Innovations International Inc.'s pipeline?

SS Innovations International Inc. (SSII) has 1 pipeline candidate tracked by BioSniper across SEC filings and clinical trial registrations.

What is SS Innovations International Inc.'s lead drug candidate?

SS Innovations International Inc.'s most advanced tracked candidate is ssi mantra (Approved) for urology, general, gynecology, colorectal, gastroenterology, head and neck, thoracic and cardiac surgeries.

What is SS Innovations International Inc.'s cash runway?

Based on its most recent reported cash balance and quarterly burn rate, SS Innovations International Inc. has approximately 47.6 months of cash runway.

What is SS Innovations International Inc.'s market capitalization?

SS Innovations International Inc.'s market capitalization is approximately $694.5M.

Who is the CEO of SS Innovations International Inc.?

Dr. Sudhir Prem Srivastava M.D. is the chief executive officer of SS Innovations International Inc. (SSII).

Get the full picture on SS Innovations International Inc.

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.